Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Wonder if Lily Buys SMMT.
$LLY
LLY offers Zepbound in_single-use_vials_at_sharply_reduced_prices—(yesterday’s news):
https://www.nytimes.com/2024/08/27/well/eli-lilly-zepbound-price.html
To quote Areosmith ' I'm back in the saddle again' . 💰
In the green premarket again. 🍷
Bought back in at open today. 🍷
In regards to new a pharma product.
Just sold my LLY shares. Wonderful way to ease into the weekend. Good luck to everyone today.
Going to be another green day.
I don't think they have sales in Europe yet, that'll change. 💰💰💰
FDA advises LLY it wants AdCom meeting. Portends delay. Meanwhile NVO CEO was interviewed on CNBC-TV this morning, repeats NVO’s PR warning dated in January 2024 that it will not have manufacturing capacity to fill demand for its weight loss drug until 2006(?).
Eli Lilly was investigating Talampanel prior to 2010
For the treatment of epilepsy, malignant gliomas and ALS
development codes LY-300164 , LY300164
results from the trial for ALS have been found negative
Talampanel is not currently under development.
It showed effectiveness for epilepsy in clinical trials but its development was suspended due to its poor pharmacokinetic profile, namely a short terminal half-life (3 hours) that necessitated multiple doses per day.
RespireRx Pharmaceuticals $ RSPI a little unknown company KRM–II–81 has shown promising results for Epilepsy.
Has fully suppressed the epileptiform activity in the excised brain tissue from a 19-year-old patient with pharmaco-resistant epilepsy.
I bought Lilly about a year ago based on Mounjaro and knowing it was going to be a success. I am a FAmily Doc who has done bariatric medicine for 30 years. Zepbound definitely is inducing more weight loss than Ozempic (Wegovy) but I am getting concerned over the number of patients that are stopping zepbound / Mounjaro due to side effects, seems a lot more than on Ozempic ( Wegovy) .
Incredible, isn’t it
What gets me about these social media bozos is they actually believe they will become Boca Raton rich by day trading sub $1 stocks
Because they are incapable of researching companies
800$ tomorrow?
Shorted at 625.
Billionaires dream a while back, speculating
Interesting company
Knew this company from the 80 ssssss
anyone here, hear enzc announced they now have a CURE for hiv/aids clone 3, yesterday on accesswire and yahoo finance.
anyone here, hear enzc announced they now have a CURE for hiv/aids clone 3, yesterday on accesswire and yahoo finance.
anyone here, hear enzc announced they now have a CURE for hiv/aids clone 3, yesterday on accesswire and yahoo finance.
RSI Moving Average Bullish Cross Over + Gap up with jump in volume.
Check out at - https://www.stockaio.com/US/ai/Stock/LLY/MovingAverage
OTCSC nice post as always.
Let's hope this gets their attention.
RGBP Is A FAR GREATER Fit Than ENZC And Here's Why!
# 1 RGBP has (24+) Disruptive Biotech Patents worth $$ BILLIONS; ENZC has only two (2).
https://patents.google.com/?inventor=David+Koos&sort=new
https://patents.justia.com/assignee/regen-biopharma-inc
https://www.otcmarkets.com/filing/html?id=15088630&guid=dk3wkKwg3iFaJth
# 2 Eli Lilly had prior collaborative arrangement with RGBP with joint I.P. claim on NR2F6 for developing an mRNA Cancer Vaccine
https://www.biospace.com/article/releases/regen-biopharma-enters-into-open-innovation-drug-discovery-program-agreement-with-eli-lilly-/
# 3 Eli Lilly-Curevac 2017 Partnership to develop mRNA Cancer Vaccine FAILED Ending June 2020 due to Curevac's faulty research data. Lilly lost $100 Million in shared development costs. Merger/Acquisition with RGBP is the shortest path to getting back on track!
# 4 Licensing of (1) Patent with (2) INDs (New Drug Applications) for treating pancreatic & colon cancer by mRNA Vaccine; The Future of Medicine
https://www.aamc.org/news-insights/mrna-technology-promises-revolutionize-future-vaccines-and-treatments-cancer-infectious-diseases
# 5 RGBP is in league with Big Pharmas developing mRNA Cancer Vaccines that Eli Lilly clearly wants to be included in, especially in the wake of their failed relationship with Curevac. It is a Trillion Dollar Market!
https://www.ventureradar.com/keyword/Cancer%20Vaccines
# 6 FDA Patent Approval
https://newsinvasion24.com/regen-biopharma-inc-otcmkts-rgbp-gets-approval-for-cancer-vaccine-patent/
# 7 Partnership:Oncology Pharma Paid $1M for Patent Licensing; will now Post Quarterly Revenues for 15 Years
# 8 Certification Audit of RGBP by BRG completed 11/15/21. This is indicative of an Industry Standard Merger/Acquisition
#9 On 4/27/21 CEO files Acquisition Intent with 8K
https://www.otcmarkets.com/filing/conv_pdf?id=14894907&guid=55ywkew26hwfJth
Opinion ONLY
Be well and prosper...
Followers
|
37
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
170
|
Created
|
04/07/08
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |